GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arix Bioscience PLC (LSE:ARIX) » Definitions » EV-to-FCF

Arix Bioscience (LSE:ARIX) EV-to-FCF : -45.81 (As of May. 26, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Arix Bioscience EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Arix Bioscience's Enterprise Value is £82.78 Mil. Arix Bioscience's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was £-1.81 Mil. Therefore, Arix Bioscience's EV-to-FCF for today is -45.81.

The historical rank and industry rank for Arix Bioscience's EV-to-FCF or its related term are showing as below:

LSE:ARIX' s EV-to-FCF Range Over the Past 10 Years
Min: -39.59   Med: -3.9   Max: -3.65
Current: -39.59

During the past 7 years, the highest EV-to-FCF of Arix Bioscience was -3.65. The lowest was -39.59. And the median was -3.90.

LSE:ARIX's EV-to-FCF is not ranked
in the Biotechnology industry.
Industry Median: 8.36 vs LSE:ARIX: -39.59

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Arix Bioscience's stock price is £1.42. Arix Bioscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was £0.115. Therefore, Arix Bioscience's PE Ratio for today is 12.35.


Arix Bioscience EV-to-FCF Historical Data

The historical data trend for Arix Bioscience's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arix Bioscience EV-to-FCF Chart

Arix Bioscience Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-FCF
Get a 7-Day Free Trial -12.05 -10.69 -18.25 -3.25 -6.69

Arix Bioscience Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -6.69 -

Competitive Comparison of Arix Bioscience's EV-to-FCF

For the Biotechnology subindustry, Arix Bioscience's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arix Bioscience's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arix Bioscience's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Arix Bioscience's EV-to-FCF falls into.



Arix Bioscience EV-to-FCF Calculation

Arix Bioscience's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=82.782/-1.807
=-45.81

Arix Bioscience's current Enterprise Value is £82.78 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Arix Bioscience's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was £-1.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arix Bioscience  (LSE:ARIX) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Arix Bioscience's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.42/0.115
=12.35

Arix Bioscience's share price for today is £1.42.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Arix Bioscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was £0.115.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Arix Bioscience EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Arix Bioscience's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Arix Bioscience (LSE:ARIX) Business Description

Traded in Other Exchanges
N/A
Address
50 Duke Street, Duke Street House, London, GBR, W1K 6JL
Arix Bioscience PLC is a healthcare and life science company. Its business model is to source, finance, and develop healthcare and life science businesses that deliver or seek to deliver therapies to patients. Its segment includes sourcing, financing, and developing healthcare and life science businesses globally.

Arix Bioscience (LSE:ARIX) Headlines

No Headlines